Biotechnology Annual Review, 1st Edition,M. Raafat El-Gewely,ISBN9780444530325
Add to Wish List
 
 
 

Volume 13: Biotechnology Annual Review, 1st Edition

Print Book

Author :   

Release Date:

Imprint: Elsevier Science

ISBN: 9780444530325

Pages: 378

Dimensions: 240 X 165

Buy print & eBook together
and save 40%

USD 250.00
Print Book

+

USD 250.00
eBook

USD 500.00Normal price

USD 300.00Bundle price

Add to Cart
Select format

Print Book Estimated Delivery Time

Hardcover

USD 250.00
USD 125.00

In Stock

eBook eBook Overview

USD 250.00
USD 125.00

PDF format

VST format

Add to Cart

Buy Print & eBook both and save 40%
View Bundle Price

 
 

Key Features

* Includes over 200 figures with more than 60 tables
* Discusses valuable information on pharming & transgenic plants
* Provides detailed information on the production of plasmid DNA for pharmaceutical use

Description

Biotechnology is a diverse, complex and rapidly evolving field. Students and experienced researchers alike face the challenges of staying on top of developments in their field of specialty and maintaining a broader overview of the field as a whole. Volumes containing competent reviews on a diverse range of topics in the field fulfill the dual role of broadening and updating biotechnologists’ knowledge. The current volume is an excellent example of such a book. The topics covered range from classical issues in biotechnology - such as, recent advances in all-protein chromophore technology- to topics that are focused on sequencing and recombinant vaccines. The information presented in this book will therefore will be of great value to both experienced biotechnologists and biotechnologists in training.

Readership

Researchers in life science and biotechnology fields

M. Raafat El-Gewely

Affiliations and Expertise

Department of Biotechnology, Institute of Medical Biology, University of Tromso, Norway

View additional works by M. Raafat El-Gewely

Biotechnology Annual Review, 1st Edition

Foreword: Biotechnology, Health, and Peace; 1. Towards a New Era in Sequencing; 2. Optimizing Scale up Yield for Protein Production: Translation Engineering and Computationally Optimized DNA Assembly (CODA); 3. Engineering, Expression, Purification, and Production of Thermolysin, an Enzyme for Aspartame Synthesis; 4. Preparation of Recombinant Vaccines; 5. Antibody Manufacturing; 6. Pharming & Transgenic Plants; 7. Protein microarray chip technology based on Porous Silicon; 8. Production of plasmid DNA for pharmaceutical use; 9. Potentials of Phenolic Molecules from Natural Sources and their Derivatives as Anti-HIV Agents; 10. Ganoderma lucidum and its Pharmaceutically Active Compounds; 11. Citric Acid Technology; 12. Nonclinical and Clinical Development of a Nanotechnology Therapeutic.
»
Biotechnology Annual Review